AACR Project GENIE® functions as a nonprofit, contract research organization (CRO) wholly owned by the American Association for Cancer Research, that operates a unique research platform. 

We collaborate with research leaders throughout the R&D lifecycle–from target discovery and trial design to post-market regulatory activities, delivering best-in-class real-world data (RWD) solutions. 

AACR Project GENIE® is powered by two tightly integrated assets: 

1. AACR Project GENIE Registry 

The world’s largest open-access, pan-cancer clinico-genomic real-world data repository (250,000+ tumors and growing). 

Delivers deeply curated, longitudinal molecular & clinical data suitable for exploratory science and regulatory engagements. 

2. AACR Project GENIE Consortium 

A legally-bound network of 20 premier academic cancer centers across North America, Europe, and Asia. 

Provides prospective data, fit-for-purpose biospecimens, and turnkey infrastructure for international multi-site studies, ensuring speed and data quality. 

Together, the AACR Project GENIE Registry and Consortium form an oncology RWD ecosystem that powers precision medicine innovation. 

To learn more about our collaborative opportunities, please email [email protected].